Chantal friebertshÄuser joins moderna as senior vice president, commercial

Newly created role will have responsibility for commercial efforts in europe, middle east and canada cambridge, ma / accesswire / december 20, 2022 / moderna, inc . (nasdaq:mrna), a biotechnology company pioneering messenger rna (mrna) therapeutics and vaccines, today announced the appointment of chantal friebertshÄuser as senior vice president, commercial, europe, middle east and canada effective january 1, 2023.
MRNA Ratings Summary
MRNA Quant Ranking